Archive for the ‘Achillion’ Category

JPM kicks off with fevered focus on the next big biotech deal

January 9th, 2012 John Carroll

The news of the Bristol-Myers/Inhibitex deal couldn’t have been better timed. With the biotech world converging on San Francisco today for the annual JP Morgan confab, there’s nothing like a 10-figure deal to get everyone whipped up about the potential…

Posted in Abbott Labs, Achillion, Biotech IPO, Blog, Boehringer Ingelheim, Bristol-Myers Squibb, Companies, Diagnostics, Funding, Hepatitis C, Idenix Pharmaceuticals, Inhibitex, Medical Devices, Medical Supply, Merck, Mergers and Acquisitions, Novartis, Pharmaceuticals, Pharmasset, Roche, Startups, Universities, vertex, Videos Tags: Comments Off
Read More »